You are here: Industry Insights > Evotec

News List

Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics expresspharma
July 04, 2019
According to Nosophorm, the initial focus will be on Chemistry, Manufacturing and Control (CMC) as well as Clinical Trial Application (CTA)-enabling and filing activities related to NOSO-502
Evotec Acquires Biotherapeutics contractpharma
July 04, 2019
$90M deal expands Evotec’s U.S. footprint in Seattle and machine learning capabilities.
Evotec Receives $23.8M TB Grant contractpharma
June 12, 2019
Aims to generate standardized, high-quality preclinical data to support novel regimen selection and development.
Evotec, Celgene Expand Strategic Alliance contractpharma
June 10, 2019
Expanded neurodegenerative alliance to include a new cell type, triggering $9.0 million payment to Evotec.
Evotec to Acquire Just Biotherapeutics in $90M Transaction contractpharma
May 29, 2019
Expands therapeutic offerings in areas such as oncology, CNS, pain, inflammation, metabolics, and infectious diseases.
Evotec to acquire biologics company Just Biotherapeutics pharmaceutical-technology
May 23, 2019
Evotec has entered a definitive agreement to acquire Just Biotherapeutics and its in-house drug development technology platform J.DESIGN.
Evotec & Indivumed Enter Research Collaboration ontractpharma
April 15, 2019
To discover and develop first-in-class therapeutics for the treatment of colorectal cancer.
Evotec and GARDP partner to identify new antibiotics pharmaceutical-technology
March 20, 2019
German drug discovery firm Evotec has partnered with Swiss non-profit The Global Antibiotic Research and Development Partnership (GARDP) to discover new antibiotics to address the growing threat of antimicrobial resistance (AMR).
Evotec and Galapagos collaborate for new fibrosis target pharmaceutical-technology
February 20, 2019
German biotechnology company Evotec has entered into a collaboration agreement with Belgo-Dutch pharmaceutical firm Galapagos for a new, undisclosed target to treat fibrosis....
Novo Nordisk inks deal with Evotec to develop small-molecule drugs for diabetes, obesity firstwordpharma
August 23, 2018
Novo Nordisk entered a strategic alliance with Evotec to develop small-molecule therapies to treat patients with diabetes and obesity, the German company said Wednesday.

Previous page 1 2 3 4 Next page